Table: Rohto - 6-MTH group results

Rohto Pharmaceutical

12/11/2020 06:00

Nov 12 (Reuters)- 
             Rohto Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2020        Sep 30, 2019     Mar 31, 2021 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               83.00               90.43           183.00    
                   (-8.2 pct)          (+3.6 pct)       (-2.8 pct)  
  Operating           10.78               10.39            21.80    
                   (+3.7 pct)          (-3.0 pct)       (-5.6 pct)  
  Recurring           11.09               10.88            22.10    
                   (+1.9 pct)          (-1.8 pct)       (-2.8 pct)  
  Net                  6.18                7.31            14.00    
                   (-15.4 pct)         (-0.2 pct)       (-9.2 pct)  
  EPS               54.17 yen           64.07 yen       122.73 yen  
  EPS Diluted       54.01 yen           63.86 yen                   
  Ann Div                               26.00 yen        27.00 yen  
  -Q2 div           13.00 yen           13.00 yen                   
  -Q4 div                               13.00 yen        14.00 yen  
  
  NOTE - Rohto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4527.T